Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;53(2):313-320.
doi: 10.1007/s11239-021-02614-0. Epub 2021 Nov 23.

Fibrinspecific liposomes as a potential method of delivery of the thrombolytic preparation streptokinase

Affiliations

Fibrinspecific liposomes as a potential method of delivery of the thrombolytic preparation streptokinase

I E Adzerikho et al. J Thromb Thrombolysis. 2022 Feb.

Abstract

The use of streptokinase (SK) in the clinic is limited by the lack of fibrin-specificity and the short half-life of the drug. We have developed a new dosage form of streptokinase (immunoliposome), which consists of "free" native streptokinase and "bound" encapsulated in liposomes conjugated through carboxylated dextran with fibrin-specific monoclonal antibodies FnI-3C (IgG2 class), in a ratio of 60 and 40%, respectively, and studied their physicochemical properties, pharmacokinetic parameters, and the ability of fibrin-specific liposomes with SK for targeted delivery to fibrin in an in vivo experiment. The obtained immunoliposomes had a hydrodynamic diameter of ~ 140 nm, a zeta potential of - 19.6 mV, and entrapment efficiency of 14.1%. Fluorescent labels bound to immunoliposomes with streptokinase selectively accumulated in model rat vein thrombi at sites containing fibrin in 30 min after injection. Studies of pharmacokinetic parameters showed that the administration of immunoliposomes with streptokinase to rats was accompanied by an increase in the half-life from 1.8 to 24.1 min, the time to reach the maximum concentration from 15 to 30 min, and a decrease in the elimination constant by about 13 times compared with the native streptokinase preparation. Further studies are needed to evaluate the thrombolytic efficacy a new dosage form of streptokinase in experiment in vivo.

Keywords: Drug delivery system; Immunoliposomes; Liposomes; Pharmacokinetics; Streptokinase.

PubMed Disclaimer

References

    1. Zhang H (2017) Thin-film hydration followed by extrusion method for liposome preparation. In: D’Souza G (ed) Liposomes. Methods in molecular biology, vol 1522. Humana Press, New York
    1. Koudelka S, Mikulik R, Mašek J, Raška M, Turánek Knotigová P, Miller AD, Turánek J (2016) Liposomal nanocarriers for plasminogen activators. J Control Release 227:45–57. https://doi.org/10.1016/j.jconrel.2016.02.019 - DOI - PubMed
    1. Sen Gupta A (2016) Cardiovascular nanomedicine: materials and technologies. In: Lu ZR, Sakuma S (eds) Nanomaterials in pharmacology. Methods in pharmacology and toxicology. Humana Press, New York, pp 251–277
    1. Ramezanpour M, Leung SS, Delgado-Magnero KH et al (2016) Computational and experimental approaches for investigating nanoparticle-based drug delivery systems. Biochim Biophys Acta 1858(7 Pt B):1688–1709. https://doi.org/10.1016/j.bbamem.2016.02.028 - DOI - PubMed
    1. Kesov PG, Reitblat OM, Safiullina ZM, Shalaev SV (2014) Evolyutsiya tromboliticheskoi terapii v lechenii infarkta miokarda [evolution of thrombolytic therapy in the treatment of myocardial infarction]. Ratsional’naya farmakoterapiya v kardiologii 10(5):554–558 - DOI

LinkOut - more resources